S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
Log in

OTCMKTS:SDMHF - Straumann Stock Price, Forecast & News

$197.00
-1.40 (-0.71 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$197.00
Now: $197.00
$197.00
50-Day Range
$144.79
MA: $184.61
$204.45
52-Week Range
$122.63
Now: $197.00
$205.05
Volume67 shs
Average Volume440 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. It offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as systems for storage and transportation of intermediate and finished biological products. The company also provides cell cultivation, fermentation, filtration, purification, and fluid management services, which supports its customers to develop and produce drugs. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Read More

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SDMHF
CUSIPN/A
CIKN/A
Phone33 4 42 84 56 00

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees6,000
Next Earnings DateN/A
OptionableNot Optionable

Receive SDMHF News and Ratings via Email

Sign-up to receive the latest news and ratings for SDMHF and its competitors with MarketBeat's FREE daily newsletter.


Straumann (OTCMKTS:SDMHF) Frequently Asked Questions

How has Straumann's stock been impacted by COVID-19 (Coronavirus)?

Straumann's stock was trading at $179.80 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SDMHF stock has increased by 9.6% and is now trading at $197.00. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Straumann?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Straumann in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Straumann.

Has Straumann been receiving favorable news coverage?

Press coverage about SDMHF stock has been trending somewhat positive on Wednesday, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Straumann earned a news impact score of 0.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutStraumann.

Who are some of Straumann's key competitors?

Who are Straumann's key executives?

Straumann's management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman & CEO (Age 55)
  • Mr. Heiko Imöhl, VP of Group Financing & Investor Relations
  • Ms. Petra Kirchhoff, VP of Corp. Communications & IR (Age 51)
  • Mr. Gerry Mackay, Exec. VP of Marketing, Sales & Services for Lab Products and Services Division (Age 57)

What is Straumann's stock symbol?

Straumann trades on the OTCMKTS under the ticker symbol "SDMHF."

How do I buy shares of Straumann?

Shares of SDMHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Straumann's stock price today?

One share of SDMHF stock can currently be purchased for approximately $197.00.

What is Straumann's official website?

The official website for Straumann is http://www.sartorius.com/.

How can I contact Straumann?

The company can be reached via phone at 33 4 42 84 56 00.


MarketBeat Community Rating for Straumann (OTCMKTS SDMHF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Straumann and other stocks. Vote "Outperform" if you believe SDMHF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SDMHF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel